查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1454241

按疾病类型、治疗类型、给药途径、分销管道和地区分類的香港脚（足癣）的全球市场。

Global Athlete's Foot Market, By Disease Type, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography .
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年全球香港脚市场价值为14.1亿足癣，预计2031年将达到20.6亿美元，年复合成长率（CAGR）预计将成长4.8%。

报告范围 报告详情
基准年 2023年 2023/2024年市场规模 14.1亿美元
实际资料 2019-2023 预测期 2024-2031
预测期2023/2024~2030/2031年复合成长率： 4.80% 2030/2031价值预测 20.6亿美元
图 1. 2024 年按地区分類的香港脚（足癣）全球市场占有率（%）
全球脚气市场-IMG1

香港脚（足癣脚）是一种常见的真菌感染疾病，会影响脚部皮肤，尤其是脚趾之间的皮肤，但也可能扩散到脚趾甲和手。这种真菌常见于运动员身上，因此被称为香港脚（香港足癣），因为它在温暖、潮湿的环境中生长，例如在运动员中很常见的出汗的鞋子中。这种情况的特征是脚趾间和脚底发痒、刺痛和灼热感。受影响的皮肤可能会变红、粗糙、破裂和起水泡。虽然令人不快，但症状通常很轻微，可以用非处方抗真菌药物治疗。在持续或严重的情况下，可能需要更积极的处方笺治疗。香港脚（足癣）是由皮癣菌（一种生长在皮肤坏死表皮中的真菌）引起的。这种真菌很容易透过直接接触受污染的表面以及间接接触毛巾、鞋子和衣服等物品传播。社区淋浴设备、游泳池和更衣室是感染的热点，运动员和健身爱好者尤其容易受到感染。足部卫生对于预防香港脚（足癣脚）起着重要作用。这包括保持足部清洁干燥、穿透气的鞋子、定期更换袜子、不要赤脚在可能存在真菌的公共场所行走等。患有香港脚（足癣脚）的人也需要小心，不要将感染传播到身体的其他部位或传染给其他人。早期发现和治疗香港脚（足癣）对于防止感染疾病变得难以控製或导致更严重的继发细菌感染非常重要。了解原因、预防和治疗方案可以帮助您有效应对这种情况并保持足部健康。

市场动态：

全球香港脚（足癣）市场主要是由于老年人口增加、肥胖率上升以及水上活动参与度增加而导致感染疾病率上升。人们对未经治疗的足部真菌感染疾病的影响的健康认识不断提高，这也推动了自我诊断和非成药的发展。然而，其他治疗选择，例如使用非处方药 (OTC) 外用乳膏和粉末的家庭疗法，可能会阻碍处方药的产生收入潜力。

本研究的主要特点

  • 该报告对全球香港脚（足癣）市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模和年复合成长率（CAGR%）。
  • 它还说明了各个细分市场的潜在商机，并为该市场提供了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球香港脚（足癣）市场的主要企业。
  • 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球香港脚（足癣）市场报告迎合了该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球香港脚（足癣）市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
  • 提高健康和卫生意识
  • 个人护理和运动保健支出增加
  • 治疗方案的技术进步
  • 主要亮点
  • 监管场景
  • 最近的趋势
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 合併、收购和合作

第四章全球香港脚（足癣）市场－冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第5章2019-2031年全球香港脚（足癣）市场，依药物类别

  • 抗真菌药物
  • 组合使用

第6章2019-2031年全球香港脚（足癣）市场（依疾病适应症）

  • 中足
  • 脚底
  • 水痘的

第 7 章 全球香港脚（足癣）市场，途径划分，2019-2031 年

  • 外用
  • 口服

第8章2019-2031年全球香港脚市场（依足癣通路）

  • 医院药房
  • 零售药房
  • 网路药房

第9章2019- 足癣年全球香港脚市场（按地区）

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第10章竞争格局

  • 公司简介
    • Perrigo Company Plc.
    • Novartis AG
    • Valeant Pharmaceuticals International
    • GlaxoSmithKline plc
    • Bayer AG
    • Teva Pharmaceuticals Industries Ltd.
    • Mylan NV
    • Glenmark Pharmaceutical Ltd
    • Taro Pharmaceutical Industries Ltd.
    • Camber Pharmaceuticals Inc
    • Aurobindo Pharma Ltd

第11章 章节

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6665

The global athlete's foot market was valued at US$ 1.41 Bn in 2023 and is expected to reach US$ 2.06 Bn by 2031, growing at a compound annual growth rate (CAGR) of 4.8% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 1.41 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 4.80% 2030/2031 Value Projection: US$ 2.06 Bn
Figure 1. Global Athlete's Foot Market Share (%), By Region, 2024
Global Athlete's Foot Market - IMG1

Athlete's foot, also known as tinea pedis, is a common fungal infection that affects the skin on the feet, particularly the spaces between the toes, but can also spread to the toenails and hands. It is named ""athlete's foot"" because it is frequently seen in athletes, as the fungus thrives in warm, moist environments, such as the inside of sweaty shoes, which are common among sports participants. This condition is characterized by itching, stinging, and burning sensations between the toes or on the soles of the feet. The affected skin may also become red, flaky, cracked, or blistered. Although the condition can be uncomfortable, it is generally mild and can be treated with over-the-counter antifungal medications. In persistent or severe cases, prescription-strength treatments may be necessary. Athlete's foot is caused by dermatophytes, a type of fungus that grows on the dead outer layer of skin. The fungus spreads easily through direct contact with contaminated surfaces or through indirect contact with towels, shoes, or clothing. Communal showers, swimming pools, and locker rooms are hotspots for transmission, making athletes and gym-goers particularly susceptible. Good foot hygiene plays a crucial role in preventing athlete's foot. This includes keeping the feet clean and dry, wearing breathable footwear, changing socks regularly, and avoiding walking barefoot in public places where the fungus may be present. Individuals with athlete's foot should also be careful not to spread the infection to other parts of their body or to other people. Early detection and treatment of athlete's foot are important to prevent the infection from becoming more difficult to manage or leading to more serious secondary bacterial infections. Understanding the causes, prevention, and treatment options enables individuals to effectively deal with this condition and maintain good foot health.

Market Dynamics:

The global athlete's foot market is primarily driven by the rising prevalence of the infection due to a growing geriatric population, increasing obesity rates, and greater participation in aquatic activities. Growing health awareness regarding implications of untreated fungal infections of feet is also supporting self-diagnosis and over-the-counter medication. However, alternative treatment options such as home remedies using over-the-counter (OTC) topical creams and powders may hinder revenue generation potential for prescription drugs.

Key features of the study:

  • This report provides in-depth analysis of the global athlete's foot market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global athlete's foot market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Perrigo Company Plc., Novartis AG, Valeant Pharmaceuticals International, GlaxoSmithKline plc, Bayer AG, Teva Pharmaceuticals Industries Ltd., Mylan NV, Glenmark Pharmaceutical Ltd, Taro Pharmaceutical Industries Ltd., Camber Pharmaceuticals Inc, Aurobindo Pharma Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global athlete's foot market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global athlete's foot market

Detailed Segmentation:

  • Global Athlete's Foot Market, By Drug Class
    • Antifungals
    • Combination
  • Global Athlete's Foot Market, By Disease Indication
    • Interdigital
    • Plantar
    • Vesicular
  • Global Athlete's Foot Market, By Route of Administration
    • Topical
    • Oral
  • Global Athlete's Foot Market, By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Athlete's Foot Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Top Companies in Global Athlete's Foot Market:
    • Perrigo Company Plc.
    • Novartis AG
    • Valeant Pharmaceuticals International
    • GlaxoSmithKline plc
    • Bayer AG
    • Teva Pharmaceuticals Industries Ltd.
    • Mylan NV
    • Glenmark Pharmaceutical Ltd
    • Taro Pharmaceutical Industries Ltd.
    • Camber Pharmaceuticals Inc
    • Aurobindo Pharma Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Athlete's Foot, By Drug Class
    • Market Athlete's Foot, By Disease Indication
    • Market Athlete's Foot, By Route of Administration
    • Market Athlete's Foot, By Distribution Channel
    • Market Athlete's Foot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
  • Growing health and hygiene awareness
  • Increasing spending on personal care and sports healthcare
  • Technological advancements in treatment options
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Athlete's Foot Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Athlete's Foot Market, By Drug Class, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Antifungals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Combination
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Athlete's Foot Market, By Disease Indication, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020-2031
    • Segment Trends
  • Interdigital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Plantar
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Vesicular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Athlete's Foot Market, By Route of Administration, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Segment Trends
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Athlete's Foot Market, By Distribution Channel, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

9. Global Athlete's Foot Market, By Region, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Country 2019 -2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

10. Competitive Landscape

  • Company Profile
    • Perrigo Company Plc.
  • Drug Class Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Novartis AG
    • Valeant Pharmaceuticals International
    • GlaxoSmithKline plc
    • Bayer AG
    • Teva Pharmaceuticals Industries Ltd.
    • Mylan NV
    • Glenmark Pharmaceutical Ltd
    • Taro Pharmaceutical Industries Ltd.
    • Camber Pharmaceuticals Inc
    • Aurobindo Pharma Ltd

Analyst Views

11. Section

  • References
  • Research Methodology
  • About us